agilon health (NYSE:AGL) Given New $5.00 Price Target at Wells Fargo & Company

agilon health (NYSE:AGL) had its target price dropped by stock analysts at Wells Fargo & Company from $6.00 to $5.00 in a report issued on Tuesday, Marketbeat Ratings reports. The firm presently has an “overweight” rating on the stock. Wells Fargo & Company‘s price objective points to a potential upside of 85.87% from the stock’s previous close.

A number of other brokerages also recently commented on AGL. Needham & Company LLC restated a “hold” rating on shares of agilon health in a research note on Friday, March 21st. Cowen restated a “hold” rating on shares of agilon health in a research note on Tuesday, April 15th. JMP Securities restated a “market perform” rating on shares of agilon health in a research note on Monday, April 28th. The Goldman Sachs Group upped their target price on shares of agilon health from $2.50 to $5.00 and gave the stock a “neutral” rating in a research note on Thursday, May 8th. Finally, Barclays increased their price objective on shares of agilon health from $2.00 to $3.00 and gave the company an “underweight” rating in a research note on Thursday, May 8th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $4.90.

agilon health Stock Performance

Shares of NYSE:AGL opened at $2.69 on Tuesday. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $1.11 billion, a price-to-earnings ratio of -2.86 and a beta of 0.38. The firm’s 50-day moving average is $4.23 and its 200 day moving average is $3.19. agilon health has a 12 month low of $1.50 and a 12 month high of $7.73.

agilon health (NYSE:AGL) last issued its earnings results on Tuesday, May 6th. The company reported $0.03 EPS for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.04. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.50 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The company’s revenue for the quarter was down 4.5% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.02) EPS. Research analysts predict that agilon health will post -0.59 EPS for the current year.

Institutional Investors Weigh In On agilon health

A number of hedge funds and other institutional investors have recently bought and sold shares of AGL. Oak Thistle LLC purchased a new stake in agilon health during the fourth quarter valued at approximately $25,000. Ieq Capital LLC purchased a new stake in agilon health during the fourth quarter valued at approximately $26,000. Signaturefd LLC lifted its position in agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock valued at $27,000 after acquiring an additional 8,467 shares during the last quarter. Humankind Investments LLC purchased a new stake in agilon health during the fourth quarter valued at approximately $30,000. Finally, Raymond James Financial Inc. purchased a new stake in agilon health during the fourth quarter valued at approximately $33,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.